ONCOSEC MEDICAL Inc Quarterly Common Stock, Shares, Outstanding from Q1 2011 to Q4 2022

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
ONCOSEC MEDICAL Inc quarterly Common Stock, Shares, Outstanding history and growth rate from Q1 2011 to Q4 2022.
  • ONCOSEC MEDICAL Inc Common Stock, Shares, Outstanding for the quarter ending January 31, 2023 was 2.97M shares, a 92.4% decline year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 2.97M -36.4M -92.4% Jan 31, 2023 10-Q 2023-03-14
Q3 2022 1.79M -37.4M -95.4% Oct 31, 2022 10-Q 2022-12-15
Q2 2022 1.79M -37.4M -95.4% Jul 31, 2022 10-Q 2023-03-14
Q1 2022 39.4M +493K +1.27% Apr 30, 2022 10-Q 2022-06-14
Q4 2021 39.3M +2.86M +7.83% Jan 31, 2022 10-Q 2022-03-15
Q3 2021 39.2M +11.5M +41.6% Oct 31, 2021 10-Q 2021-12-15
Q2 2021 39.2M +16.1M +69.8% Jul 31, 2021 10-K 2022-10-31
Q1 2021 38.9M +16.1M +70.7% Apr 30, 2021 10-Q 2021-06-11
Q4 2020 36.5M +25.7M +239% Jan 31, 2021 10-Q 2021-03-15
Q3 2020 27.7M +17M +159% Oct 31, 2020 10-Q 2020-12-11
Q2 2020 23.1M +12.4M +117% Jul 31, 2020 10-K 2021-10-29
Q1 2020 22.8M +15.7M +220% Apr 30, 2020 10-Q 2020-06-15
Q4 2019 10.8M -53.9M -83.4% Jan 31, 2020 10-Q 2020-03-16
Q3 2019 10.7M -49M -82.1% Oct 31, 2019 10-Q 2019-12-13
Q2 2019 10.6M +5.28M +98.7% Jul 31, 2019 10-K 2020-10-28
Q1 2019 7.11M -44.8M -86.3% Apr 30, 2019 10-Q 2019-06-14
Q4 2018 64.6M +28.8M +80.4% Jan 31, 2019 10-Q 2019-03-08
Q3 2018 59.7M +30.1M +102% Oct 31, 2018 10-Q 2018-12-14
Q2 2018 5.35M -16.3M -75.2% Jul 31, 2018 10-K/A 2019-11-27
Q1 2018 51.9M +30.7M +145% Apr 30, 2018 10-Q 2018-06-13
Q4 2017 35.8M +16.1M +81.5% Jan 31, 2018 10-Q 2018-03-09
Q3 2017 29.6M +10M +51.2% Oct 31, 2017 10-Q 2017-12-07
Q2 2017 21.6M +3.58M +19.9% Jul 31, 2017 10-K 2018-10-19
Q1 2017 21.2M +4.2M +24.7% Apr 30, 2017 10-Q 2017-06-01
Q4 2016 19.7M +2.76M +16.3% Jan 31, 2017 10-Q 2017-03-16
Q3 2016 19.6M +4.76M +32.1% Oct 31, 2016 10-Q 2016-12-08
Q2 2016 18M +3.22M +21.7% Jul 31, 2016 10-K 2017-10-25
Q1 2016 17M +4.62M +37.4% Apr 30, 2016 10-Q 2016-06-09
Q4 2015 17M -230M -93.1% Jan 31, 2016 10-Q 2016-03-08
Q3 2015 14.8M -230M -93.9% Oct 31, 2015 10-Q 2015-12-08
Q2 2015 14.8M +2.59M +21.2% Jul 31, 2015 10-K 2016-10-13
Q1 2015 12.4M -204M -94.3% Apr 30, 2015 10-Q 2015-06-09
Q4 2014 247M +56.7M +29.8% Jan 31, 2015 10-Q 2015-03-12
Q3 2014 245M +73.8M +43.2% Oct 31, 2014 10-Q 2014-12-08
Q2 2014 12.2M -106M -89.6% Jul 31, 2014 10-K 2015-10-14
Q1 2014 216M +98.4M +83.5% Apr 30, 2014 10-Q 2014-06-13
Q4 2013 190M +72.4M +61.4% Jan 31, 2014 10-Q 2014-03-14
Q3 2013 171M +82.7M +93.8% Oct 31, 2013 10-Q 2013-12-16
Q2 2013 118M +30.2M +34.3% Jul 31, 2013 10-K 2014-10-10
Q1 2013 118M +30M +34.2% Apr 30, 2013 10-Q 2013-06-14
Q4 2012 118M +61M +107% Jan 31, 2013 10-Q 2013-03-15
Q3 2012 88.2M +31.3M +55.1% Oct 31, 2012 10-Q 2012-12-17
Q2 2012 87.9M +31M +54.5% Jul 31, 2012 10-K 2013-09-27
Q1 2012 87.9M +19.4M +28.3% Apr 30, 2012 10-Q 2012-06-14
Q4 2011 56.9M Jan 31, 2012 10-Q 2012-03-16
Q3 2011 56.9M Oct 31, 2011 10-Q 2011-12-15
Q2 2011 56.9M Jul 31, 2011 10-K 2012-10-15
Q1 2011 68.5M Mar 2, 2011 10-K 2014-10-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.